Article Correctness Is Author's Responsibility: Investigational Alzheimer’s Drug Improves Biomarkers of the Disease

The article below may contain offensive and/or incorrect content.

This shows a head made of cogwheelsGantenerumab, an investigational drug for Alzheimer's disease, reduced amyloid plaques and lowered tau levels in the brains of people with genetic risk factors for the neurodegenerative disorder.